QIAGEN N.V. Net Income Loss

• QIAGEN N.V. showed an increase of +408.3% in Net Income Loss from 2024 to 2025.
• This data is from QIAGEN N.V.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), QIAGEN N.V.'s Net Income Loss has grown by 377.2%.
• Historical annual values: Fiscal year 2025: $424.88 million | Fiscal year 2024: $83.59 million | Fiscal year 2023: $341.30 million | Fiscal year 2022: $423.21 million | Fiscal year 2021: $512.60 million | Fiscal year 2020: $359.19 million | Fiscal year 2019: -$41.46 million | Fiscal year 2018: $190.38 million | Fiscal year 2017: $40.39 million | Fiscal year 2016: $80.40 million | Fiscal year 2015: $130.15 million | Fiscal year 2014: $116.37 million | Fiscal year 2013: $69.07 million | Fiscal year 2012: $129.51 million | Fiscal year 2011: $96.04 million | Fiscal year 2010: $144.31 million | Fiscal year 2009: $137.77 million | Fiscal year 2008: $89.03 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026